MRI and clinical differences between optic pathway tumours in children with and without neurofibromatosis

British Journal of Radiology

Volumn 74, Issue 877, 2001, Pages 24-31

  Chateil, J F ^a   Soussotte, C ^a   Pedespan J M ^a   Brun, M ^a   Le Manh, C ^a   Diard, F ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; ASTROCYTOMA; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MALE; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE GLIOMA; OPTIC NERVE TUMOR; PATHOLOGICAL ANATOMY; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR DIAGNOSIS; TUMOR GROWTH; TUMOR LOCALIZATION;

EID: 0035133637     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.74.877.740024     Document Type: Article

References (37)

1. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference
2. Prognostic significance of type 1 neurofibromatosis (von Recklinghausen disease) in childhood optic glioma
3. Optic pathway tumors in children: The effect of neurofibromatosis type 1 on clinical manifestations and natural history
4. Long-term follow up of 69 patients treated for optic pathway tumours before the chemotherapy era
5. Visual pathway glioma: An erratic tumour with therapeutic dilemmas
6. Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal study
7. Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the NF1 Optic Pathway Glioma Task Force
8. An association between optic glioma and other tumours of the central nervous system in neurofibromatosis type 1
9. MR of visual pathways in patients with neurofibromatosis
10. Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1
11. Precocious puberty in children with neurofibromatosis type 1
12. Optic gliomas in children with neurofibromatosis type 1
13. Central nervous system tumors of childhood
14. Magnetic resonance imaging signs of optic nerve gliomas in neurofibromatosis 1
15. The architecture of optic nerve gliomas with and without neurofibromatosis
16. The "pseudo-CSF" signal of orbital optic glioma on magnetic resonance imaging: A signature of neurofibromatosis
17. Orbital optic glioma in neurofibromatosis. Magnetic resonance diagnosis of perineural arachnoidal gliomatosis
18. Orbit, skull base, and pharynx: Contrast-enhanced fat suppression MR imaging
19. Juvenile pilocytic astrocytomas: CT and MR characteristics
20. The phakomatoses: Part I. Neurofibromatosis and tuberous sclerosis
21. Neurofibromatosis type 1: Magnetic resonance imaging findings
22. MRI findings in children with neurofibromatosis type 1: A prospective study
23. Neurofibromatosis types 1 and 2: Cranial MR findings
24. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1
25. Spontaneous regression of optic glioma in a patient with neurofibromatosis
26. Spontaneous decrease of a pilocytic astrocytoma in neurofibromatosis type 1
27. Spontaneous visual improvement in chiasmal gliomas
28. Spontaneous involution of optic pathway lesions in neurofibromatosis type 1: Serial contrast MR evaluation
29. Chiasmal glioma in neurofibromatosis type 1 with severe visual loss regained with radiation
30. Screening for optic gliomas in neurofibromatosis type 1: The role of neuroimaging
31. Pilocytic astrocytoma: Correlation between the initial imaging features and clinical aggressiveness
32. Optic pathway gliomas in neurofibromatosis
33. Proliferative activity as measured by MIB-1 labeling index and long-term outcome of visual pathway astrocytomas in children
34. Supratentorial pilocytic astrocytomas. A clinicopathologic, prognostic, and flow cytometric study of 51 patients
35. Potential prognostic factors of relapse-free survival in childhood optic pathway glioma: A multivariate analysis
36. Cytogenetics and molecular genetics of nervous system tumors
37. Specific learning disability in children with neurofibromatosis type 1: Significance of MRI abnormalities